{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:32:34Z","timestamp":1777426354235,"version":"3.51.4"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI104823"],"award-info":[{"award-number":["R01AI104823"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["2229-65843177 , 0552 \u2013 2015"],"award-info":[{"award-number":["2229-65843177 , 0552 \u2013 2015"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"publisher","award":["172715657"],"award-info":[{"award-number":["172715657"]}],"id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00657","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:12:22Z","timestamp":1560989542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Deninson Alejandro","family":"Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Dario","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro Jos\u00e9","family":"Mart\u00ednez-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Cossio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl E. V.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.S.","family":"Burchmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Adelaida","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1590\/S0102-86502010000500014","article-title":"Profile of wound healing process induced by allantoin","volume":"25","author":"Ara\u00fajo","year":"2010","journal-title":"Acta Cir. Bras."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.rvsc.2013.08.004","article-title":"Oxidative stress in mice treated with antileishmanial meglumine antimoniate","volume":"95","author":"Bento","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0006-2952(87)90689-7","article-title":"Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes","volume":"36","author":"Berman","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/elps.201200007","article-title":"CE-ESI-MS metabolic fingerprinting of Leishmania resistance to antimony treatment","volume":"33","author":"Canuto","year":"2012","journal-title":"Electrophoresis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1021\/ac2021823","article-title":"Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction","volume":"83","author":"Creek","year":"2011","journal-title":"Anal. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/bioinformatics\/bts069","article-title":"IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data","volume":"28","author":"Creek","year":"2012","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0006-2952(02)00843-2","article-title":"Cytoprotective role of taurine in a renal epithelial cell culture model","volume":"63","author":"Eppler","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"B12","unstructured":"eCFR\u2014Code of Federal RegulationseCFR\u2014Code Fed. Regul. Part 211 Subpart E 211.941978"},{"key":"B13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12192-011-0276-4","article-title":"Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats","volume":"16","author":"Ganesan","year":"2011","journal-title":"Cell Stress Chaperones"},{"key":"B14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0009-2797(97)00087-2","article-title":"Arsenic and antimony: comparative approach on mechanistic toxicology","volume":"107","author":"Gebel","year":"1997","journal-title":"Chem. Biol. Interact."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003820","article-title":"Ex vivo host and parasite response to antileishmanial drugs and immunomodulators","volume":"9","author":"Gonzalez-Fajardo","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B16","unstructured":"eCFR\u2014Code of Federal Regulations\n            GovernmentU. S.\n          Electron. Code Fed. Regul.2010"},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s002440010265","article-title":"Antioxidant effect of taurine against lead-induced oxidative stress","volume":"41","author":"G\u00fcrer","year":"2001","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-010611-134748","article-title":"Xenobiotic metabolomics: major impact on the metabolome","volume":"52","author":"Johnson","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/bmj.1.2662.10","article-title":"A new cell proliferant: its clinical application in the treatment of ulcers","volume":"1","author":"Macalister","year":"1912","journal-title":"Br. Med. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.4317\/medoral.21281","article-title":"The effects of a topical gel containing chitosan, 0,2% chlorhexidine, allantoin and despanthenol on the wound healing process subsequent to impacted lower third molar extraction","volume":"21","author":"Madrazo-Jimenez","year":"2016","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"B22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0026-0495(89)90148-0","article-title":"Utilization of intravenously administered N-acetyl-L-glutamine in humans","volume":"38","author":"Magnusson","year":"1989","journal-title":"Metabolism."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00726-012-1361-4","article-title":"Taurine and inflammatory diseases","volume":"46","author":"Marcinkiewicz","year":"2014","journal-title":"Amino Acids"},{"key":"B24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"B25","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events v4.0 (CTCAE)2009"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.3390\/nu5093481","article-title":"The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway","volume":"5","author":"Obeid","year":"2013","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006141","article-title":"Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation","volume":"12","author":"Olliaro","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"Olliaro","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutananeous leishmaniasis due to Leishmania Viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mrfmmm.2003.07.015","article-title":"Metal-induced apoptosis: mechanisms","volume":"533","author":"Pulido","year":"2003","journal-title":"Mutat. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1586\/14787210.2013.824718","article-title":"Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review","volume":"11","author":"Requena-M\u00e9ndez","year":"2013","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","article-title":"Protein biomarker discovery and validation: the long and uncertain path to clinical utility","volume":"24","author":"Rifai","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1172\/JCI112446","article-title":"Identification of 3-methylglutarylcarnitine","volume":"77","author":"Roe","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0130675","article-title":"A multiplatform metabolomic approach to the basis of antimonial action and resistance in Leishmania infantum","volume":"10","author":"Rojo","year":"2015","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1021\/ac2000994","article-title":"PeakML\/mzMatch: a file format, Java Library, R Library, and Tool-Chain for mass spectrometry data analysis","volume":"83","author":"Scheltema","year":"2011","journal-title":"Anal. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4269\/ajtmh.18-0643","article-title":"Eligibility for local therapies in adolescents and adults with cutaneous Leishmaniasis from southwestern Colombia: a cross-sectional study","volume":"100","author":"Uribe-Restrepo","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data","volume":"7","author":"van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/0264-6021:3610417","article-title":"Carnitine biosynthesis in mammals","volume":"361","author":"Vaz","year":"2002","journal-title":"Biochem. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"V\u00e9lez","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005140","article-title":"Metabolomics identifies multiple candidate biomarkers to diagnose and stage human African trypanosomiasis","volume":"10","author":"Vincent","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.1.e19","article-title":"Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant\u2019s newborn screening card","volume":"108","author":"Wood","year":"2001","journal-title":"Pediatrics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/2213235X11301010092","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2012","journal-title":"Curr. Metabolomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bcp.2005.10.043","article-title":"Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell line","volume":"71","author":"Wyllie","year":"2006","journal-title":"Biochem. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T01:44:15Z","timestamp":1569289455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":50,"alternative-id":["10.3389\/fphar.2019.00657"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00657","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"article-number":"657"}}